Jennifer E. Cohn, MD MPH
Clinical Associate Professor of Medicine (Infectious Diseases)
Associate Fellow, Penn Center for Public Health Initiatives
Attending Physician, Hospital of the University of Pennsylvania
Site Director, Penn GHERT in Geneva, Switzerland
Scholar, Penn Center for Global Health
Department: Medicine
Contact information
Hospital of the University of Pennsylvania
3400 Spruce St
3rd Floor Silverstein, Suite E
Philadelphia, PA 19104
3400 Spruce St
3rd Floor Silverstein, Suite E
Philadelphia, PA 19104
Office: 2156626832
Education:
BA (Human Biology & Psychology)
Brown University, 1999.
MD
University of Pennsylvania, 2004.
MPH (Global Health)
Johns Hopkins School of Public Health, 2011.
Permanent linkBA (Human Biology & Psychology)
Brown University, 1999.
MD
University of Pennsylvania, 2004.
MPH (Global Health)
Johns Hopkins School of Public Health, 2011.
Selected Publications
Lemaire JF, Cohn J, Kakayeva S, et al.: Improving TB detection among children in routine clinical care through intensified case finding in facility-based child health entry points and decentralized management: A before-and-after study in Nine Sub-Saharan African Countries. PLOS Glob Public Health 5(4), 2024.Bamford A, Masini T, Williams P, Sharland M, Gigante V, Dixit D, Sati H, Huttner B, Bin Nisar Y, Cappello B, Were W, Cohn J, Penazzato M; PADO-antibiotics participants. : Tackling the threat of antimicrobial resistance in neonates and children: outcomes from the first WHO-convened Paediatric Drug Optimisation exercise for antibiotics. Lancet Child Adolesc Health. 2024.
Tchakounte Youngui B, Atwine D, Otai D, Vasiliu A, Ssekyanzi B, Sih C, Kana R, Arinaitwe R, Cuer B, Simo L, Okello R, Tchendjou P, Casenghi M, Kuate AK, Turyahabwe S, Cohn J, Bonnet M, Tchounga BK; CONTACT Study Group. : Integration of HIV Testing in a Community Intervention for Tuberculosis Screening Among Household Contacts of Patients with Tuberculosis in Cameroon and Uganda. J Acquir Immune Defic Syndr. 2024.
da Costa R, Kothari K, Valmont T, Srinivasan S, Cohn J, Franceschi F, Hawser S. : In vitro activity of cefiderocol against carbapenem-resistant Pseudomonas aeruginosa (CRPA) clinical isolates from countries with high CRPA incidence, 2019-2022. ESCMID Global. Barcelona, Spain. 2024 2024.
Cohn J, Balasegaram M, Srinivasan H, Menghaney L, Mpundu M, Waning B, Alimi Y.: Improving equitable access for effective antibacterial: an ecosystem approach Clin Microbiol Infect. 2024.
Aitcheson N, Sacks E, Nyamundaya TH, Muchuchuti C, Cohn J.: The Cascade of Care for Early Infant Diagnosis in Zimbabwe: Point of Care HIV Testing at Birth and 6-8 Weeks. Pediatr Infect Dis J. 2024.
da Costa R, Kothari K, Valmont T, Srinivasan S, Cohn J, Franceschi F, Hawser S. : In vitro activity of cefiderocol against carbapenem-resistant Acinetobacter baumannii (CRAB) clinical isolates from countries with high CRAB incidence, 2019-2022. ESCMID Global. Barcelona, Spain. 2024 2024.
Laxminarayan R, Impalli I, Rangarajan R, Cohn J, Ramjeet K, Trainor BW, Strathdee S, Sumpradit N, Berman D, Wertheim H, Outterson K, Srikantiah P, Theuretzbacher U. : Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance. Lancet 2024.
Cohn J, Mendelson M, Kanj SS, Shafiq N, Boszczowski I, Laxminarayan R. : Accelerating antibiotic access and stewardship: a new model to safeguard public health. Lancet Infect Dis. 2024.
da Costa R, Kothari K, Valmont T, Srinivasan S, Cohn J, Franceschi F, Hawser S. : In vitro activity of cefiderocol against carbapenem-resistant Enterobacterales (CREs) clinical isolates from countries with high CRE incidence, 2019-2022. ESCMID Global. Barcelona, Spain. 2024 2024.